Table 1 Preoperative demographic, clinical, echocardiographic, angiographic and haemodynamic data
| Â | overall | AS | AS+AR | p |
|---|---|---|---|---|
Number of patients | 110 | 56 | 54 | Â |
Age (years) mean ± S.D. | 60,5 ± 9,4 | 64,2 ± 5,64 | 56,7 ± 11,0 | 0,00003 |
Sex (n,% female) | 33 (30) | 21 (38) | 12 (22) | 0,0805 |
NYHA class mean ± S.D. | 2,39 ± 0,49 | 2,34 ± 0,48 | 2,44 ± 0,50 | 0,7207 |
Symptoms (months) mean ± S.D. | 18,1 ± 15,9 | 20,2 ± 16,8 | 15,9 ± 14,6 | 0,1599 |
Hypertension n,(%) | 39 (35) | 29 (52) | 10 (18) | 0,0003 |
Diabetes mellitus n,(%) | 7 (10) | 6 (11) | 1 (2) | 0,0569 |
Hiperlipoproteinemia n,(%) | 23 (41) | 15 (27) | 8 (14) | 0,1227 |
Bicuspid aortic valve n,(%) | 33 (30) | 11 (20) | 20 (37) | 0,0426 |
Atrial fibrilation n,(%) | 4 (4) | 3 (5) | 1 (2) | 0,3262 |
LV EDVi (ml/m2) mean ± S.D. | 81,7 ± 21,2 | 71,3 ± 16,0 | 92,6 ± 29,2 | 0,0001 |
LV ESVi (ml/m²) mean ± S.D. | 35,1 ± 15,4 | 28,9 ± 13,7 | 41,5 ± 22,9 | 0,0008 |
LV EF (%) mean ± S.D. | 59 ± 14 | 60 ± 13 | 57 ± 15 | 0,2192 |
LV EF < 45% n,(%) | 18 (16) | 7 (13) | 11 (20) | 0,2646 |
LVMi (g/m²) mean ± S.D. | 112,3 ± 20,5 | 106,9 ± 19,0 | 117,93 ± 20,6 | 0,0046 |
ΔP eho max (mmHg) mean ± S.D. | 98 ± 29 | 98 ± 22 | 98 ± 35 | 0,9894 |
ΔP eho mean (mmHg) mean ± S.D. | 63 ± 19 | 63 ± 16 | 62 ± 22 | 0,9393 |
Coronary artery disease n,(%) | 29 (26) | 18 (32) | 11 (20) | 0,1454 |
ΔP cath (mmHg) mean ± S.D. | 85,3 ± 28,3 | 89,7 ± 25,8 | 81,1 ± 30,3 | 0,2455 |